Literature DB >> 8261409

Pharmacokinetics of a fluorescent drug using laser-induced fluorescence.

J K Frisoli1, E G Tudor, T J Flotte, T Hasan, T F Deutsch, K T Schomacker.   

Abstract

Laser-induced fluorescence has been used to measure tissue levels of chloroaluminum sulfonated phthalocyanine in vivo in an implanted hamster cheek pouch carcinoma tumor model. The drug was excited at 610 nm via a pulsed nitrogen laser-pumped dye laser, and fluorescence intensity was monitored at 684 nm for up to 30 days after drug administration. Data were acquired noninvasively with high temporal and spatial resolution using the laser-induced fluorescence apparatus and were analyzed with a multicompartment pharmacokinetic model. In addition, our published data on a C6-BAG glioma rat brain tumor model were analyzed to illustrate the effect of different tumor models on the rates. The rates extracted from the pharmacokinetic model elucidate the mechanisms of drug uptake and retention in the cheek pouch and brain tumor models. The laser-induced fluorescence approach should lead to better drug dosimetry for photochemotherapy and allow quick characterization of the pharmacokinetics of new photosensitizers in tissue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8261409

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2005-08-10       Impact factor: 3.631

2.  Optimal parameters for near infrared fluorescence imaging of amyloid plaques in Alzheimer's disease mouse models.

Authors:  S B Raymond; A T N Kumar; D A Boas; B J Bacskai
Journal:  Phys Med Biol       Date:  2009-10-01       Impact factor: 3.609

3.  In vivo fluorescence imaging of the transport of charged chlorin e6 conjugates in a rat orthotopic prostate tumour.

Authors:  M R Hamblin; M Rajadhyaksha; T Momma; N S Soukos; T Hasan
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

4.  A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.

Authors:  A Orenstein; G Kostenich; L Roitman; Y Shechtman; Y Kopolovic; B Ehrenberg; Z Malik
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

5.  High content screening as high quality assay for biological evaluation of photosensitizers in vitro.

Authors:  Gisela M F Vaz; Edyta Paszko; Anthony M Davies; Mathias O Senge
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.